You are here:Home-Chemical Inhibitors & Agonists-Ras-Raf-MAPK-ERK Pathway-Raf-BRAF inhibitor Compound Ia
BRAF inhibitor Compound Ia

Chemical Structure : BRAF inhibitor Compound Ia

CAS No.: 2649372-20-1

BRAF inhibitor Compound Ia

Catalog No.: PC-72243Not For Human Use, Lab Use Only.

BRAF inhibitor Compound Ia is a potent, selective, brain penetrant BRAF inhibitor with binding Kd of 0.6, 1.2, and 1.7 nM for BRAF WT, BRAF V600E, and c-RAF, presenting paradox breaker properties.

Packing Price Stock Quantity
5 mg $188 In stock
10 mg $298 In stock
25 mg $498 In stock
50 mg $758 In stock
100 mg $1280 In stock
1 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: 98.4% (HPLC) Select Batch:

Biological Activity

BRAF inhibitor Compound Ia is a potent, selective, brain penetrant BRAF inhibitor with binding Kd of 0.6, 1.2, and 1.7 nM for BRAF WT, BRAF V600E, and c-RAF, presenting paradox breaker properties.
Compound Ia displays high selectivity profile conducted on 403 kinases with only one exception for the binding to the kinase BRK (Kd=156 nM).
Compound Ia demonstrated potent kinase inhibitory activity across all BRAF mutants with IC50 values of <1.77 nM, including the clinical relevant BRAF mutants V600E/K/A/D.
Compound Ia was designed to avoid paradoxical MAPK hyperactivation in non-BRAF V600E models, an undesired property of the three currently approved BRAFi.
Compound Ia exerted cytotoxic activity within a range of 5.2 to 30.2 nM in a collection of 94 cell lines representative of various histologic and genetic backgrounds.
Compound Ia drives prolonged MAPK inhibition, triggers superior antitumor activity in vivo in BRAF V600E models compared with dabrafenib and encorafenib.
Compound Ia is active in RAF dimer-mediated resistant tumors driven by the NRAS Q61K mutation, Compound Ia is highly brain penetrant and triggers potent antitumor activity in brain metastatic models of melanoma.

Physicochemical Properties

M.Wt 461.444
Formula C20H17F2N5O4S
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

(R)-N-(2-cyano-4-fluoro-3-((3-methyl-4-oxo-3,4-dihydroquinazolin-6-yl)oxy)phenyl)-3-fluoropyrrolidine-1-sulfonamide

References

1. Wichmann J, et al. Clin Cancer Res. 2022 Feb 15;28(4):770-780.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: